OCT4 promotes VEGF-C expression and activates the VEGFR-3 phosphokinase activity and the downstream signaling pathways, thus inducing EMT in cancer cells and ultimately enhancing tumor invasion and metastasis, promoting tumor progression, and severely affecting patient prognosis. Here, FLT4 is linked to neoplasm.